Bacteriophages, viruses that specifically target and eliminate bacteria, utilize “genetic hotspots” to evolve rapidly and overcome bacterial defenses, according to a study published Thursday in Nature Microbiology. By generating a diverse population of offspring rather than identical copies, these viruses “hedge their evolutionary bets,” potentially offering a new strategy for treating drug-resistant infections.
How Bacteriophages “Hedge Their Bets”
Researchers at Michigan State University have discovered that certain bacteriophages—or phages—do not simply mass-produce exact replicas of themselves. Instead, they leverage specific, highly mutable regions of their genomes to create a “zoo” of genetically diverse offspring. According to Chris Waters, a faculty member in Michigan State University’s Ecology, Evolution, and Behavior program, this mechanism allows the viruses to persist even when bacteria develop resistance mechanisms designed to identify and destroy invading phage DNA.
The study focused on bacteriophage T2, which infects E. coli. When the research team introduced a bacterial defense system into the host cells, the phages initially faced resistance. However, within hours, the phages consistently overcame these barriers. Genetic sequencing revealed that the viruses had accumulated repeated mutations in a gene known as agt. This region functions as a “contingency locus,” where the virus’s DNA-copying machinery slips during replication, creating reversible frameshift mutations.
Did you know?
The “contingency loci” identified by researchers accumulate mutations thousands of times faster than the rest of the phage genome, allowing the virus to rapidly adapt its genetic instructions to evade host defenses.
Broadening the Scope: Beyond T2 Phages
This evolutionary strategy is not unique to the T2 bacteriophage. Through experimental evolution and genome sequencing, the Michigan State team identified similar contingency loci in the E. coli phage T4. The research suggests that these simple sequence repeats are widespread across diverse E. coli phages, though their prevalence varies depending on the specific functions of the affected genes.
This finding provides a significant update to the scientific understanding of viral evolution. While bacteria have long been known to evolve resistance to antibiotics, these phages possess a built-in countermeasure that allows them to “hedge their bets,” ensuring that at least some members of the viral population can continue to infect and kill the target bacteria.
Implications for Future Phage Therapy
As the global health community seeks alternatives to traditional antibiotics, phage therapy has regained scientific interest. Phages were used therapeutically as early as the 1920s, but their popularity waned with the widespread availability of antibiotics like penicillin. Today, the rise of antimicrobial resistance has reignited the search for targeted bacterial treatments.
The primary advantage of phage therapy is its high specificity; unlike many broad-spectrum antibiotics, individual phages can target specific bacterial strains without harming beneficial microbes. However, this specificity is also a vulnerability, as bacteria can evolve resistance to the phages used in treatment. According to Waters, understanding how phages fight back against bacterial defenses could allow scientists to engineer more resilient therapies. While eliminating resistance entirely remains unlikely, researchers aim to harness these evolutionary tricks to minimize it.
Frequently Asked Questions
What is a bacteriophage?
A bacteriophage is a type of virus that exclusively infects and kills bacteria. It does not affect human cells.
Why do bacteria develop resistance to phages?
Bacteria evolve defense systems to recognize and destroy the genetic material of invading phages, much like they evolve resistance to traditional antibiotics.
How can this research help treat superbugs?
By identifying the “hotspots” that phages use to evolve, scientists hope to develop more resilient phage therapies that can keep pace with bacterial defense mechanisms, potentially providing a solution for infections that are no longer responsive to antibiotics.
Is phage therapy a new medical practice?
Interest in the field is currently increasing due to the global rise in antimicrobial resistance.
Have questions about the future of antimicrobial research? Subscribe to our newsletter for the latest updates on medical science and evolutionary biology.
Worth a look